Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 801–900 of 1,001
Alzarea, S., Abbas, M., Ronan, P. J., Lutfy, K., & Rahman, S. (2022) · Brain Sciences · doi:10.3390/brainsci12111493 · Cited by 17
Hashimoto, O., Kuniishi, H., Nakatake, Y., Yamada, M., Wada, K., & Sekiguchi, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.013 · Cited by 17
Knopp, R. C., Baumann, K. K., Wilson, M. L., Banks, W. A., & Erickson, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042377 · Cited by 17
“In mice, SBs are easily monitored by evaluating locomotion, food intake, and weight loss, and these behaviors are regulated by pro-inflammatory cytokine signaling in the brain [19,20].”
BackgroundInfluentialZhang, Q., Zhang, S., Cao, X., Zhi, Y., & Guo, Y. C. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128391 · Cited by 19
Electroacupuncture attenuates LPS-induced depression-like behavior through kynurenine pathway
Wu, X., Hu, R., Jiang, S., Di, Z., Chen, Y., Shi, M., Chen, B., He, K., Qian, K., Guo, Q., et al. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1052032 · Cited by 20
“Bodyweight measurement To investigate alterations in mice’s physical conditions during the LPS-challenged, an electronic balance was used to determine the weight of each mouse 2, 6, and 24 h after LPS (O’connor et al., 2009).”
MethodBiomarkers of stress resilience: A review
Paribello, P., Branchi, I., Viglione, A., Mancini, G. F., Morena, M., Campolongo, P., & Manchia, M. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104052 · Cited by 18
“Notably, particular emphasis has been placed on indoleamine 2,3-dioxygenase (IDO), given its association with elevated levels of depression-like phenotypic markers in preclinical models (Andre et al., 2014; Dinel et al., 2014; O ’ Connor et al., 2009a; O ’ Connor et al., 2009b).”
Kim, J. S., Kim, J. H., Eo, H., Ju, I. G., Son, S.-R., Kim, J., Jang, D. S., & Oh, M. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04094-8 · Cited by 17
“Therefore, suppressing glial cell activation and reducing proinflammatory mediators and cytokines may be a treatment strategy for neurological diseases LPS is a well-known inducer of inflammation in experiments of BV2 cells [37, 38].”
Li, Y., Zhan, B., Zhuang, X., Zhao, M., Chen, X., Wang, Q., Liu, Q., & Zhang, L. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03142-3 · Cited by 19
Filho, A. J. M. C., Mottin, M., Soares, M. V.-R., Jucá, P. M., Andrade, C. H., & Macêdo, D. S. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000585 · Cited by 19
“These findings were subsequently corroborated (O’Connor et al., 2009).”
ResultChompré, G., Sambolin‐Escobales, L., Cruz, M. L., Sanchez, R., Rodriguez, Y., Rodríguez-Santiago, R. E., Yamamura, Y., & Appleyard, C. B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11194 · Cited by 17
Girard, R., Chauhan, P. S., Tucker, T. A., Allen, T., Kaur, J., Jeffers, A., Koenig, K. B., Florova, G., Komissarov, A. A., Gaidenko, T. A., et al. (2019) · Experimental Brain Research · doi:10.1007/s00221-019-05682-0 · Cited by 17
Chen, H., Piao, J., Geng, Z., Han, X., Li, R., Cui, R., & Li, B. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115071 · Cited by 18
Yuan, Z., Yang, H., Wang, P., Hou, X., Xu, K., Zhou, Y., Dai, R., Gao, Y., Gao, X., Guo, Q., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.07.018 · Cited by 17
Qiu, T., Guo, J., Wang, L., Shi, L., Ai, M., Zhu, X., Peng, Z., & Kuang, L. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6825 · Cited by 27
“This systemic inflammation can be recapitulated in rodent model systems through the peripheral injection of lipopolysaccharide (LPS) or other immunostimulatory compounds [7].”
Backgroundde Souza-Júnior, F. J. C., Cunha, L. C., & Lisboa, S. F. D. S. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00028 · Cited by 16
Guo, J., Fang, M., Xiong, Z., Zhou, K., & Zeng, P. H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02628-w · Cited by 17
Xu, F.-R., Wei, Z., Xu, X.-X., Zhang, X., Wei, C., Qi, X., Li, Y., Gao, X., & Wu, Y. H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02976-7 · Cited by 17
“This dose was chosen because it elicits a pro-inflammatory cytokine response in the brain, resulting in depressive-like behavior in mice [9, 28].”
BackgroundMethodMeier, T. B., Savitz, J. B., España, L. Y., Goeckner, B. D., Teague, T. K., van der Horn, H. J., Muftuler, L. T., Mayer, A. R., & Brett, B. L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.015 · Cited by 17
Kang, X., Xie, Z., Yang, Y. J., Wu, L., Xu, H., Zhang, S., Liang, Y., & Wu, X. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.010 · Cited by 16
Sick and Tired: Mood, Fatigue, and Inflammation in Cancer
Kruse, J. L., & Strouse, T. B. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0555-3 · Cited by 18
Casaril, A. M., Domingues, M., Lourenço, D. D. A., Vieira, B. M., Begnini, K. R., Corcini, C. D., França, R. T., Varela, A. S., Seixas, F. K., Collares, T. V., et al. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109278 · Cited by 17
Chi, X., Xue, X., Pan, J., Wu, J., Shi, H., Wang, Y., Lu, Y., Zhang, Z., & Ma, K. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2121843 · Cited by 17
“LPS, a highly effective and powerful inducer of inflammatory cytokines (such as TNF-a, IL-1 and IL-6), is often used to construct a model of depression by activating the peripheral or central innate immune systems (O’Connor et al. 2009; Wu et al. 2016).”
BackgroundRen, H., Lin, F., Wu, L., Tan, L., Lu, L., Xie, X., Zhang, Y., Bao, Y., Ma, Y., Huang, X., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114237 · Cited by 17
Nuovi sviluppi dell’ipotesi serotoninergica della depressione: shunt del triptofano
Marazziti, D., Baroni, S., Picchetti, M., Piccinni, A., Silvestri, S., & Dell’Osso, L. (2013) · Rivista di psichiatria · doi:10.1708/1228.13612 · Cited by 25
“Nel topo, infatti, la somministrazione di KYN da sola è in grado di indurre sia depressione sia sintomi d’ansia (62,63).”
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 16
NMDA Receptors and Signaling in Chronic Neuropathic Pain
Laumet, G. O., Chen, S., & Pan, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-49795-2_6 · Cited by 18
Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models
Ordway, G. A., Szebeni, A., Hernandez, L. J., Crawford, J. D., Szebeni, K., Chandley, M. J., Burgess, K. C., Miller, C. A., Bakkalbasi, E., & Brown, R. W. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx068 · Cited by 20
Kongsui, R., Sriraksa, N., & Thongrong, S. (2020) · BioMed Research International · doi:10.1155/2020/4259316 · Cited by 21
“Numerous studies have reported that the injection of LPS also produced memory deficit and sickness-like behavior including decreased locomotor activity, anorexia, body weight loss, increased anxiety, and somnolence [11, 18, 19] which are considered to be very similar to the clinically important symptoms of neurodegene…”
BackgroundWei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
Relationship between CRP and depression: A genetically sensitive study in Sri Lanka
Zavos, H. M. S., Zunszain, P. A., Jayaweera, K., Powell, T. R., Chatzivasileiadou, M., Harber-Aschan, L., Adikari, A., Pannala, G., Siribaddana, S., Badini, I., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.003 · Cited by 15
Cortisol is a potent modulator of lipopolysaccharide-induced interferon signaling in macrophages
Billing, A. M., Fack, F., Turner, J. D., & Muller, C. P. (2011) · Innate Immunity · doi:10.1177/1753425910369269 · Cited by 15
Zhang, J., Zhou, Y., Mei, X., Yan, S., Mao, J. Y., Li, Y., Bian, Z., Li, L., Ji, D., Lu, T., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03763-w · Cited by 21
Wang, L., Feng, Z., Zheng, T., Dai, G., Wang, M., Zhou, L., Zheng, Y., & Chen, G. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110675 · Cited by 15
Blaes, A. H., Nair, C., Everson‐Rose, S. A., Jewett, P. I., Wolf, J. M., & Zordoky, B. N. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-28895-4 · Cited by 18
Roxadustat (FG-4592) abated lipopolysaccharides-induced depressive-like symptoms via PI3K signaling
Li, A., Liu, Z., Ali, T., Gao, R., Luo, Y., Gong, Q., Zheng, C., Li, W., Guo, H., Liu, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1048985 · Cited by 16
Xu, Y., Li, W., Shi, M., Xu, X., Guo, D., Liu, Z., Chen, L., Zhong, X., & Cao, W. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109560 · Cited by 16
Exploring the Bioactive Compounds in Some Apple Vinegar Samples and Their Biological Activities
Abdali, Y. E., Saghrouchni, H., Kara, M., Mssillou, I., Allali, A., Jardan, Y. A. B., KAFKAS, N. E., El-Assri, E.-M., Nafidi, H., Bourhia, M., et al. (2023) · Plants · doi:10.3390/plants12223850 · Cited by 18
Bian, X., Wang, Q., Wang, Y., & Lou, S. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1305208 · Cited by 15
Ma, X., Xue, S., Ma, H., Saeed, S., Zhang, Y., Meng, Y., Chen, H., Yu, H., Wang, H., Hu, S., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.062 · Cited by 16
Deep, S. N., Baitharu, I., Sharma, A., Gurjar, A. K. S., Prasad, D. N., & Singh, S. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153371 · Cited by 17
RetractedGrécias, L., Hébert, F.-O., Berger, C. S., Barber, I., & Aubin‐Horth, N. (2016) · Journal of Experimental Biology · doi:10.1242/jeb.151456 · Cited by 20
Bahrami, Z., Firouzi, M., Hashemi-monfared, A., Zahednasab, H., & Harirchian, M. H. (2017) · Cytokine · doi:10.1016/j.cyto.2017.12.013 · Cited by 15
“It has been demonstrated that LPS is able to induce depression-like in mice resulting in heightened levels of IDO expression [19].”
BackgroundFox, H. C., Milivojevic, V., MacDougall, A., LaVallee, H., Simpson, C. A., Angarita, G. A., & Sinha, R. (2019) · Addiction Biology · doi:10.1111/adb.12832 · Cited by 16
Zheng, L. J., Li, L., Zhong, J., Zhang, Z., Ye, Y. B., Zhang, X. Y., Wang, Y. F., Zhang, H., Liu, Y., Lu, G., et al. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00223-3 · Cited by 17
Savitz, J. B., Ford, B. N., Yeh, H., Akeman, E., Cosgrove, K. T., Clausen, A. N., Martell, C. R., Kirlić, N., Santiago, J., Teague, T. K., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720004389 · Cited by 15
Significance of vagus nerve function in terms of pathogenesis of psychosocial disorders
Kakinuma, Y. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104934 · Cited by 16
Reconsidering the reasons for heightened inflammation in major depressive disorder
Palmos, A., Chung, R., Frissa, S., Goodwin, L., Hotopf, M. H., Hatch, S. L., Breen, G. D., & Powell, T. R. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.109 · Cited by 16
Tito, P. A. L., Bernardino, T. C. D. S., Bellozi, P. M. Q., da Silva, M. C. M., de Miranda, A. S., Vieira, É. L. M., Moreira, F. A., Palotás, A., de Oliveira, A. C. P., & Reis, H. J. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00301-8 · Cited by 16
Marco, R. D., Barritt, A. W., Cercignani, M., Cabbai, G., Colasanti, A., & Harrison, N. A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.04.010 · Cited by 16
“One of the downstream consequences of minocycline’s anti-inflammatory activity is that it appears to inhibit inflammation-induced upregulation of indolamine 2,3 dioxygenase (IDO) (Henry et al., 2008; O’Connor et al., 2009).”
Bhatt, S., Mahesh, R., Jindal, A., & Devadoss, T. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.05.002 · Cited by 16
Platt, B. J., Schulenberg, J., Klee, N., Nizami, M., & Clark, J. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2923-6 · Cited by 17
Poon, D. C.-H., Ho, J. Y. S., You, R., Tse, H.-L., Chiu, K., & Chang, R. C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0433-2 · Cited by 17
“Previous literature has shown that these two types of sickness components can be temporally [11, 92–94] and pharmacologically [27, 29, 93, 94] dissociated, indicating that the two”
BackgroundLee, S. A., Mefford, J., Huang, Y., Witte, J. S., Martin, J. N., Haas, D. W., McLaren, P. J., Mushiroda, T., Kubo, M., Byakwaga, H., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001124 · Cited by 15
“Translocation of microbial products, including LPS, may stimulate Toll-like receptors, which then induce IDO activity [25].”
BackgroundTran, H., Shin, E., Saito, K., Tran, T.-V., Phan, D., Sharma, N., Kim, D. W., Choi, S. Y., Jeong, J. H., Jang, C., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110986 · Cited by 15
Matsuura, S., Nishimoto, Y., Endo, A., Shiraki, H., Suzuki, K., & Segi‐Nishida, E. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00729 · Cited by 14
Sun, R., Tang, M., Yang, D., Zhang, Y.-Y., Xu, Y.-H., Qiao, Y., Yu, B., Cao, S.-X., Wang, H., Huang, H.-Q., et al. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102614 · Cited by 14
“LPS-induced depressive-like behaviors typically emerge 1 d post LPS i.p. injection when apparent sickness behaviors (especially reduced locomotion) diminish (Lasselin et al., 2020; O ’ Connor et al., 2009; Sekio and Seki, 2014).”
BackgroundCiani, M., Rigillo, G., Benatti, C., Pani, L., Blom, J. M. C., Brunello, N., Tascedda, F., & Alboni, S. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240705143649 · Cited by 16
Ong, L. T., & Sia, C. (2025) · Biology · doi:10.3390/biology14040336 · Cited by 16
Pardeshi, G. N., Ali, N., Shirasath, K. R., Goyal, S. N., Nakhate, K. T., & Awathale, S. N. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01763-5 · Cited by 16
Andreetta, F., Barnes, N. M., Wren, P. B., & Carboni, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.05.014 · Cited by 14
“This hypothesis was also confirmed by the finding that KYN injected in rat brain dose dependently caused depressive-like behaviour (O'Connor et al., 2009).”
ResultIrinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
Levi, M., Ben‐Aharon, I., & Shalgi, R. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.812053 · Cited by 14
Fraga-Junior, E. B., Fernandes, I. L., Rohden, C. A. H., Doneda, D. L., Ynoue, H. N., Rios-Santos, F., Lima, E., Buss, Z. S., & Vandresen-Filho, S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.014 · Cited by 16
Spohr, L., Soares, M. S. P., Bona, N. P., Luduvico, K. P., Alves, A. G., Domingues, W. B., Blödorn, E. B., Bortolatto, C. F., Brüning, C. A., Campos, V. F., et al. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03813-8 · Cited by 17
Wang, H., Zhai, Y., Lei, Z., Chen, S., Sun, M., Yin, P., Duan, Z., & Wang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171351 · Cited by 20
Tanaka, M., & Kinney, D. K. (2011) · Psychological Reports · doi:10.2466/02.12.17.pr0.108.3.977-992 · Cited by 15
McGuiness, B., Gibney, S. M., Beumer, W., Versnel, M. A., Sillaber, I., Harkin, A., & Drexhage, H. A. (2016) · NeuroImmunoModulation · doi:10.1159/000446370 · Cited by 14
Ladha, S., Qiu, X., Casal, L. L., Caron, N. S., Ehrnhoefer, D. E., & Hayden, M. R. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0043-8 · Cited by 15
Dornbierer, D., Boxler, M. I., Voegel, C. D., Stucky, B., Steuer, A. E., Binz, T. M., Baumgartner, M. R., Baur, D. M., Quednow, B. B., Kræmer, T., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz047 · Cited by 15
Tufvesson‐Alm, M., Imbeault, S., Liu, X.-C., Zheng, Y., Faka, A., Choi, D., Schwieler, L., Engberg, G., & Erhardt, S. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577401 · Cited by 16
The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice
Aoki, S., Deyama, S., Sugie, R., Ishimura, K., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113676 · Cited by 15
Sekine, A., & Fukuwatari, T. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.004 · Cited by 15
Exposure to Hypobaric Hypoxia and Reoxygenation Induces Transient Anxiety-Like Behavior in Rat
Baitharu, I., Jain, V., Deep, S. N., Kumar, G., & Ilavazhagan, G. (2013) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2013.38063 · Cited by 14
“Forced Swim Test The forced swim test (FST), a standardized test of depression-like behavior in which depression is inferred from increased duration of immobility, was conducted as described previously [19].”
Methodde Bartolomeis, A., Fornaro, M., Scopetta, E., Ricci, C., Irano, A., Simone, G. D., Comai, S., Iasevoli, F., & Caiazza, C. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.10.005 · Cited by 14
Agarwal, S., Vyas, P., Nirwan, N., & Vohora, D. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108262 · Cited by 14
Wang, S., Cai, Q., Xu, L., Sun, Y., Wang, M., Wang, Y., Zhang, L., Li, K., & Ni, Z. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06413-8 · Cited by 16
Lao, Y., Li, Z., Bai, Y., Li, W., Wang, J., Wang, Y., Li, Q., & Dong, Z. (2023) · Pain Research and Management · doi:10.1155/2023/2061632 · Cited by 13
“Activation of microglia was observed in the rodent models of LPS-induced depression [78], and the activation of indoleamine 2,3-dioxygenase (IDO) in microglia was found critical for the development of depression-like symptoms and LPS-induced microglia activation [79, 80].”
BackgroundKhoo, S. C., Zhang, N., Luang‐In, V., Goh, M. S., Sonne, C., & Ling, N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118441 · Cited by 15
Qin, Y. F., Hu, X., Zhao, H., Kurban, N., Chen, X., Yi, J., Zhang, Y., Cui, S., & Zhang, Y.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137496 · Cited by 14
“Then, it was diluted using 0.9% sterile sodium chloride solution to the final treatment concentration of 50 µ g/mL, according to the antidepressant effective dose of 1-MT [77].”
MethodInfluentialLan, L., Chen, C.-Y., Wang, Y., Guo, Z., & Zhang, Y. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111401 · Cited by 13
Core features and inherent diversity of post-acute infection syndromes
Trautmann, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1509131 · Cited by 14
“Evidence for these links are multiple, as summarized by (253): 1) Injecting mice with LPS or in fl ammatory cytokines induces a depression-like behavior.”
Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-α
Budni, J., Moretti, M., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113512 · Cited by 15
GluN2A-ERK-mTOR pathway confers a vulnerability to LPS-induced depressive-like behaviour
Francija, E., Lukić, I., Petrovic, Z., Brkic, Z., Mitić, M., Radulović, J., & Adžić, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113625 · Cited by 13
Balter, L. J. T., Li, X., Schwieler, L., Erhardt, S., Axelsson, J., Olsson, M. J., Lasselin, J., & Lekander, M. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106110 · Cited by 13
“, 2020), partly based on research of induction of depressive-like behavior in rodents (Lawson et al., 2013; O’Connor et al., 2009).”
BackgroundAdeleke, P. A., Ajayi, A. M., Ben‐Azu, B., & Umukoro, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02519-0 · Cited by 17
Chunchai, T., Chinchapo, T., Sripetchwandee, J., Thonusin, C., Chattipakorn, N., & Chattipakorn, S. C. (2024) · Acta Physiologica · doi:10.1111/apha.14130 · Cited by 15
“15 Microglia are the resident immune cells in the brain that play crucial roles in normal brain functions.”
BackgroundAre Mood and Anxiety Disorders Inflammatory Diseases?
Boorman, E., Romano, G. F., Russell, A., Mondelli, V., & Pariante, C. M. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150501-06 · Cited by 15
Knockout of NPFFR2 Prevents LPS-Induced Depressive-Like Responses in Mice
Yu, Z., Lin, Y., & Chen, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147611 · Cited by 16
“In particular, peripheral LPS delivery is an effective method to activate hippocampal TLR4 [25,28] among other responses, and the treatment readily stimulates depressive-like behaviors [42,44].”
BackgroundHao, K., Qu, Q., Hao, H., Wang, G., Chen, Y., Liang, Y. L., & Xie, L. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054981 · Cited by 15
“In these conditions, depressive symptoms were induced by proinflammatory cytokines (PCs), mainly interleukin1b (IL-1b), interleukin-6 (IL-6), interferon-c (IFN-c), and tumor necrosis factor-alpha (TNF-a) [4,5].”
BackgroundFuture Directions of Cytokine Hypothesis in Depression: ‘NLRP3 inflamazomu’
Şahin, C., & Arıcıoğlu, F. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20130927070724 · Cited by 19
Avitsur, R., Paley, S., Franko, M., Wolff, N., Eyal, N., & Doron, R. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.020 · Cited by 13
Cheng, D., Murtaza, G., Ma, S., Li, L., Li, X., Tian, F., Zheng, J., & Lu, Y. (2017) · Molecules · doi:10.3390/molecules22101614 · Cited by 14
“Besides, there are many other conditions in which LPS-induced depressive-like behavior is observed such as decrease in diet intake and acute behavioral response [52].”
BackgroundEngler, H., Brinkhoff, A., Wilde, B., Kribben, A., Rohn, H., Witzke, O., Schedlowski, M., & Benson, S. (2023) · NeuroImmunoModulation · doi:10.1159/000534444 · Cited by 15
“For example, the LPS doses used in animals are much higher compared to humans, which can lead to impairment of the blood-brain barrier and consequently a prolonged central in fl am-matory response [43, 46, 47].”
BackgroundTryptophan and its role in sleep and mood
Yousef, P., Rosen, J., & Shapiro, C. M. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15589-5.00001-3 · Cited by 20
Alzarea, S. I., Khan, A., Ronan, P. J., Lutfy, K., & Rahman, S. (2024) · Brain Sciences · doi:10.3390/brainsci14030290 · Cited by 13
GluN2A: A Promising Target for Developing Novel Antidepressants
Wang, G., Wang, Q., Liu, Q.-H., & Guan, W. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae037 · Cited by 12
“…suggested that LPS provokes tryptophan–kynurenine metabolic pathway dysregulation and results in the synthesis of the neurotoxic NMDA glutamate agonists quinolinic acid and 3-hydroxykynurenine, thereby enhancing oxidative stress and contributing to depressive-like behavior (O’Connor et al., 2009).”
Akif, A., & Islam, M. R. (2026) · Comprehensive physiology · doi:10.1002/cph4.70100 · Cited by 14
The Role of Gut Mucins in the Etiology of Depression
Rivet-Noor, C. R., & Gaultier, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.592388 · Cited by 13
“This increase in the production of kynurenine is correlated with depressivesymptoms and injection of this metabolite is sufficient to induce depressive-like behaviors in animals (O’Connor et al., 2008).”
BackgroundDahlqvist, G., Renaud, S., Barjon, C., Lefebvre, A., Aoudjehane, L., Horsmans, Y., Delhem, N., & Conti, F. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152031 · Cited by 12
Disturbed sensitive equilibrium led by stress‐induced inflammation in psychiatric illness
Zhao, H., Jin, R., & Hu, J. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100910 · Cited by 12
“IDO activation leads to the degradation of tryptophan to kynurenine and other derivatives, 35 which is a precursor of 5-hydroxytryptamine, and decreased tryptophan levels affect monoamine synthesis and delivery.”
BackgroundMinocycline mitigated enduring neurological consequences in the mice model of sepsis
Hosseini, M., Bardaghi, Z., Askarpour, H., Jafari, M. M., Golkar, A., Shirzad, S., Rajabian, A., & Salmani, H. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.114856 · Cited by 13
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.